Literature DB >> 16423955

MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 1, observer agreement.

Evguenia J Karimova1, Shesh N Rai, Xin Deng, David J Ingle, Amy C Ralph, Michael D Neel, Sue C Kaste.   

Abstract

OBJECTIVE: The aim of this study was to determine whether a new MRI-based staging system for osteonecrosis of the knee in pediatric patients could be used with an acceptable level of intra- and interobserver agreement.
MATERIALS AND METHODS: We conducted a retrospective analysis of MRI studies of the knee performed in a single institution between April 1994 and July 2003. Knee osteonecrosis was identified in 168 children with a primary diagnosis of hematologic malignancy. This substantial number prompted us to design a staging system for use with pediatric patients. To assess interobserver reliability of two primary observers in using the system, they reviewed and interpreted the same 36 imaging studies of randomly chosen patients. For the assessment of intraobserver reproducibility, each observer rereviewed 16 studies. A senior observer coded potential causes of disagreement between the primary observers.
RESULTS: Interobserver agreement was substantial: the kappa value was 0.66 (95% confidence interval [CI], 0.58-0.75) in locations where the observers had to record only the presence or absence of a lesion, and the weighted kappa value was 0.65 (95% CI, 0.59-0.72) in locations where they had to classify the extent of involvement. The presence of marrow edema, punctate foci of altered signal, and mottled marrow changes was associated with a higher level of disagreement between the primary observers.
CONCLUSION: Our proposed classification system, developed specifically for use with MRI, was used with substantial intra- and interobserver agreement. We think its use can contribute to a standardized approach to the interpretation of MRI findings in pediatric osteonecrosis of the knee.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423955     DOI: 10.2214/AJR.04.1598

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

Review 1.  Osteonecrosis in children after therapy for malignancy.

Authors:  Sue C Kaste; Evguenia J Karimova; Michael D Neel
Journal:  AJR Am J Roentgenol       Date:  2011-05       Impact factor: 3.959

Review 2.  MR imaging of osteonecrosis of the knee in children with acute lymphocytic leukemia.

Authors:  E Jane Karimova; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2007-09-01

3.  How does osteonecrosis about the knee progress in young patients with leukemia?: a 2- to 7-year study.

Authors:  E J Karimova; A Wozniak; J Wu; M D Neel; S C Kaste
Journal:  Clin Orthop Relat Res       Date:  2010-06-26       Impact factor: 4.176

4.  The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus.

Authors:  T C M Castro; H Lederman; M T A Terreri; W I Caldana; S C Kaste; M O Hilário
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

5.  Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.

Authors:  Sue C Kaste; Deqing Pei; Cheng Cheng; Michael D Neel; W Paul Bowman; Raul C Ribeiro; Monika L Metzger; Deepa Bhojwani; Hiroto Inaba; Patrick Campbell; Jeffrey E Rubnitz; Sima Jeha; John T Sandlund; James R Downing; Mary V Relling; Ching-Hon Pui; Scott C Howard
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

6.  Widespread osteonecrosis in children with leukemia revealed by whole-body MRI.

Authors:  Paivi Maria Miettunen; Lucie Lafay-Cousin; Gregory M T Guilcher; Alberto Nettel-Aguirre; Vijay Moorjani
Journal:  Clin Orthop Relat Res       Date:  2012-09-25       Impact factor: 4.176

7.  Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging.

Authors:  S Sharma; W-H Leung; P Deqing; J Yang; R Rochester; L Britton; M D Neel; K K Ness; S C Kaste
Journal:  Bone Marrow Transplant       Date:  2011-12-12       Impact factor: 5.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.